XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
The effects of the restatement on the line items within the Company’s condensed consolidated balance sheets as of June 30, 2018 are as follows:
 
 
 
June 30, 2018
 
 (
U.S. dollars in thousands)
 
As
originally
reported
 
 
Adjustments
 
 
As restated
 
CURRENT LIABILITIES:
 
 
 
 
 
 
 
 
 
 
 
 
Contracts liability
 
 
-
 
 
 
3,420
 
 
 
3,420
 
Total current liabilities
 
$15,072
 
 
$3,420
 
 
$18,492
 
LONG TERM LIABILITIES:
 
 
 
 
 
 
 
 
 
 
 
 
Contracts liability
 
 
31,885
 
 
 
(10,249)
 
 
21,636
 
Total long term liabilities
 
 
86,220
 
 
 
(10,249)
 
 
75,971
 
Total liabilities
 
 
101,292
 
 
 
(6,829)
 
 
94,463
 
CAPITAL DEFICIENCY
 
$(49,571)
 
$6,829
 
 
$(42,742)
 
The effects of the restatement on the line items within the Company’s condensed consolidated statements of operations for the three months and six months ended June 30, 2018 are as follows:
 
  
Three Months Ended June 30, 2018
  
Six Months Ended June 30, 2018
 
(
U.S. dollars in thousands, except per share data)
 
As
originally
reported
  
Adjustments
  
As
restated
  
As
originally
reported
  
Adjustments
  
As
restated
 
REVENUES FROM LICENSE AGREEMENTS
 $-  $2,832  $2,832  $-  $4,993  $4,993 
OPERATING LOSS
  (9,576)  2,832   (6,744)  (16,888)  4,993   (11,895)
LOSS FOR THE PERIOD
  (11,294)  2,832   (8,462)  (20,694)  4,993   (15,701)
Net loss per share of common stock-basic and diluted $(0.08) $0.02  $(0.06) $(0.14) $0.03  $(0.11)
 
The effects of the restatement on the line items within the Company’s condensed consolidated statements of changes in capital deficiency for the six months ended June 30, 2018 are as follows:
 
 
  
Six Months Ended June 30, 2018
 
(
U.S. dollars in thousands)
 
As
originally
reported
  
Adjustments
  
As restated
 
Net loss for the six months ended June 30, 2018
 $(20,694) $4,993  $(15,701)
Balances as of June 30, 2018
            
Accumulated deficit  (318,626)  6,829   (311,797)
Total capital deficiency $(49,571) $6,829  $(42,742)
 
Although there was with no impact to net cash provided by operating activities, net cash used in investing activities or net cash used in financing activities, the effects of the restatement on the line items within the condensed consolidated statements of cash flows for the six months ended June 30, 2018 are as follows:
 
 
  
Six Months Ended June 30, 2018
 
(
U.S. dollars in thousands)
 
As
originally
reported
  
Adjustments
  
As restated
 
Cash flows from operating activities:
            
Net loss $(20,694) $4,993   (15,701)
Increase in contracts liability  5,034   (4,993)  41 
Net cash used in operating activities
 
$
(17,377
)
 
$
-
 
 
$
(17,377
)
 
The impacts of the restatement have been reflected throughout the financial statements, including the applicable footnotes, as appropriate.
 
In addition, in connection with the agreement with Chiesi, the Company should have recognized $1.8 million of revenue in the last quarter of 2017 and accordingly has revised certain items in its consolidated financial statements for December 31, 2017 presented herein. The Company evaluated the materiality of the error from quantitative and qualitative perspectives, and concluded that the error was immaterial to the Company’s prior annual consolidated financial statements. Since the revision was not material to any prior interim period or annual consolidated financial statements, no amendments to previously filed interim or annual periodic reports was required. Consequently, the Company revised the historical consolidated financial information presented herein. Below are amounts as reported and as adjusted for December 31, 2017:
 
  
December 31, 2017
 
 
(U.S. dollars in thousands)
 
As
originally
reported
  
Adjustments
  
As
revised
 
Contracts liability $26,851  $(1,836) $25,015 
Accumulated deficit  (297,932)  1,836   (296,096)
 
The loss and weighted average number of shares outstanding used to calculate (loss) earnings per share were as follows:
 
  
Six Months Ended
  
Three Months Ended
 
  
June 30, 2018
  
June 30, 2017
  
June 30, 2018
  
June 30, 2017
 
(
U.S. dollars in thousands, except share amounts)
 
(as restated)
 
 
(as restated)
 
Net loss (income) for the period $(15,701) $(58,698) $(8,462) $450 
Financial income, net of convertible notes  -   -   -  $(11,847)
Loss used for the computation of diluted loss per share $(15,701) $(58,698) $(8,462) $(11,397)
Weighted average shares of common stock outstanding for basic calculation  145,985,445   126,000,782   146,644,450   127,523,706 
Weighted average dilutive effect of shares issuable upon conversion of convertible notes  -   -   -   65,066,683 
Weighted average dilutive effect of stock options  -   -   -   8,000 
Weighted average shares of common stock outstanding for diluted calculation  145,985,445   126,000,782   146,644,450   192,598,389